National Academy of Agricultural Sciences (NAAS)
|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
Malaria-endemic countries in Africa have recorded the lowest number of covid-19 cases and deaths compared to other countries. Pre-existing Naturally acquired Immunity to malaria was an hypothesis that was stated to explain this situation. In a context where malaria is endemic, we carried out this study in order to investigate the existence of antibody cross-reactivity between COVID-19 and malaria and to estimate the seroprevalence of COVID-19 during the third year of the pandemic in the plateau central Region in Burkina Faso. Samples collected in 2007 and positive for IgG against Plasmodium falciparum alpha-helical coiled coil proteins were used to look for a possible antibody cross-reactivity with SARS-CoV-2 antigens. Samples collected in 2022 were used to estimate the seroprevalence of COVID-19. A total of 628 individuals of both sexes, aged over 5 years were enrolled. The seroprevalence of anti-SARS-CoV-2 antibodies was measured using an ELISA test and an RDT. All the samples collected in 2007 showed no cross-reactivity between SARS-CoV-2 and Plasmodium falciparum. The seroprevalence during the third year of the pandemic was 100% and 86.88% respectively by ELISA and RDT. The proportions of IgG and IgM antibodies were respectively 86.56% and 2.81%. The results did not show antibody cross-reactivity between SARS-CoV2 and Plasmodium falciparum in the study population. High exposure to SARS-CoV-2 was found in the study area in 2022. Due to their high specificity, WANTAI ELISA and Right Sign RDT can be considered as good serological tools for COVID-19 serosurveillance in a context where malaria is endemic.
Baker, O. R., M. K. Grabowski, R. M. Galiwango, A. Nalumansi, J. Serwanga, W. Clarke, Y. H. Hsieh, R. E. Rothman, R. E. Fernandez, D. Serwadda, J. Kagaayi, T. Lutalo, S. J. Reynolds, P. Kaleebu, T. C. Quinn, and O. Laeyendecker. (2021). Differential Performance of CoronaCHEK SARS-CoV-2 Lateral Flow Antibody Assay by Geographic Origin of Samples, J Clin Microbiol, 59: e0083721.
https://doi.org/10.1128/jcm.00837-21.
Borrega, R., D. K. S. Nelson, A. P. Koval, N. G. Bond, M. L. Heinrich, M. M. Rowland, R. Lathigra, D. J. Bush, I. Aimukanova, W. N. Phinney, S. A. Koval, A. R. Hoffmann, A. R. Smither, A. R. Bell-Kareem, L. I. Melnik, K. J. Genemaras, K. Chao, P. Snarski, A. B. Melton, J. E. Harrell, A. A. Smira, D. H. Elliott, J. A. Rouelle, G. Sabino-Santos, Jr., A. C. Drouin, M. Momoh, J. D. Sandi, A. Goba, R. J. Samuels, L. Kanneh, M. Gbakie, Z. L. Branco, J. G. Shaffer, J. S. Schieffelin, J. E. Robinson, D. N. Fusco, P. C. Sabeti, K. G. Andersen, D. S. Grant, M. L. Boisen, L. M. Branco, and R. F. Garry. (2021). 'Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra Leoneans', Viruses, 13. https://doi.org/10.3390/v13112325
Emmerich, P., C. Murawski, C. Ehmen, R. von Possel, N. Pekarek, L. Oestereich, S. Duraffour, M. Pahlmann, N. Struck, D. Eibach, R. Krumkamp, J. Amuasi, O. Maiga-Ascofare, R. Rakotozandrindrainy, D. Asogun, Y. Ighodalo, S. Kann, J. May, E. Tannich, and C. Deschermeier. (2021). 'Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin', Trop Med Int Health, 26: 621-31. https://doi.org/10.1111/tmi.13569
Gebhard, C., V. Regitz-Zagrosek, H. K. Neuhauser, R. Morgan, and S. L. Klein. (2020). 'Impact of sex and gender on COVID-19 outcomes in Europe', Biol SexDiffer, 11: 29. https://doi.org/10.1186/s13293-020-00304-9
Ige, F., Y. Hamada, L. Steinhardt, N. C. Iriemenam, M. Uwandu, S. M. Greby, M. Aniedobe, B. L. Salako, M. X. Rangaka, I. Abubakar, and R. Audu. (2021). 'Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population', MicrobiolSpectr, 9: e0068021. https://doi.org/10.1128/Spectrum.00680-21
Ioannidis, J. P. A., and D. G. Contopoulos-Ioannidis. (2023). 'Prepandemic cross-reactive humoral immunity to SARS-CoV-2 in Africa: Systematic review and meta-analysis', Int J Infect Dis, 134: 160-67. https://doi.org/10.1016/j.ijid.2023.06.009
Iriemenam, N. C., F. A. Ige, S. M. Greby, O. O. Okunoye, M. Uwandu, M. Aniedobe, S. O. Nwaiwu, N. Mba, M. Okoli, N. E. William, A. Ehoche, A. Mpamugo, A. Mitchell, K. A. Stafford, A. N. Thomas, T. Olaleye, O. O. Akinmulero, N. P. Agala, A. G. Abubakar, A. Owens, S. E. Gwyn, E. Rogier, V. Udhayakumar, L. C. Steinhardt, D. L. Martin, M. I. Okoye, and R. Audu. (2023). 'Comparison of one single-antigen assay and three multi-antigen SARS-CoV-2 IgG assays in Nigeria', J Clin Virol Plus, 3: 100139. https://doi.org/10.1016/j.jcvp.2023.100139
Kabore, O. D., A. Poda, C. A. Ouattara, F. N. Michodigni, A. A. Belem, Y. Sawadogo, J. Zoungrana, L. Galal, C. Z. Meda, S. Godreuil, and A. S. Ouedraogo. (2023). 'Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country', PLoS One, 18: e0286665. https://doi.org/10.1371/journal.pone.0286665
Lapidus, S., F. Liu, A. Casanovas-Massana, Y. Dai, J. D. Huck, C. Lucas, J. Klein, R. B. Filler, M. S. Strine, M. Sy, A. B. Deme, A. S. Badiane, B. Dieye, I. M. Ndiaye, Y. Diedhiou, A. M. Mbaye, C. T. Diagne, I. Vigan-Womas, A. Mbengue, B. D. Sadio, M. M. Diagne, A. J. Moore, K. Mangou, F. Diallo, S. D. Sene, M. N. Pouye, R. Faye, B. Diouf, N. Nery, Jr., F. Costa, M. G. Reis, M. C. Muenker, D. Z. Hodson, Y. Mbarga, B. Z. Katz, J. R. Andrews, M. Campbell, A. Srivathsan, K. Kamath, E. Baum-Jones, O. Faye, A. A. Sall, J. C. Q. Velez, M. Cappello, M. Wilson, C. Ben-Mamoun, R. Tedder, M. McClure, P. Cherepanov, F. A. Some, R. K. Dabire, C. E. E. Moukoko, J. B. Ouedraogo, Y. Boum, 2nd, J. Shon, D. Ndiaye, A. Wisnewski, S. Parikh, A. Iwasaki, C. B. Wilen, A. I. Ko, A. M. Ring, and A. K. Bei. (2022). 'Plasmodium infection is associated with cross-reactive antibodies to carbohydrate epitopes on the SARS-CoV-2 Spike protein', Sci Rep, 12: 22175. https://doi.org/10.1038/s41598-022-26709-7
Mangano, V. D., Y. Kabore, E. C. Bougouma, F. Verra, N. Sepulveda, C. Bisseye, F. Santolamazza, P. Avellino, A. B. Tiono, A. Diarra, I. Nebie, K. A. Rockett, S. B. Sirima, D. Modiano, and G. E. N. Consortium Malaria. (2015). 'Novel Insights Into the Protective Role of Hemoglobin S and C Against Plasmodium falciparum Parasitemia', J Infect Dis, 212: 626-34. https://doi.org/10.1093/infdis/jiv098
MSHP. (2023). Rapport de situation de l'évaluation de la COVID-19 au Burkina Faso.
Ouédraogo, Oumarou, Luisa Nunziangeli, Edith C. Bougouma, Youssouf Kaboré, Amidou Diarra, Blami Koté, Alfred B. Tiono,GiampietroCorradin, Valentina Mangano, David Modiano, Yves Traoré, Sodiomon B. Sirima, Roberta Spaccapelo, and Issa Nébié. (2019). Seroreactivity of populations living in endemic area of Burkina Faso to Plasmodium falciparum alpha-helical coiled coil proteins motifs by protein microarray. JTDPH, 7: 1-10. https://doi.org/10.35248/2329-891X.19.7.320.
Ouedraogo, S., I. T. Traore, D. Kania, N. F. Kabore, A. MamguemKamga, H. Badolo, M. Yara, G. Sanou, A. Kone, S. T. Kagone, E. Ouedraogo, B. Konate, R. Medah, N. de Rekeneire, A. Poda, A. E. Diendere, B. Ouedraogo, O. Billa, G. Paradis, H. Tinto, and T. S. Dabakuyo-Yonli. (2023). 'The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation', Influenza Other RespirViruses, 17: e13216.
Pedersen, J., I. H. Koumakpayi, G. Babuadze, M. Baz, O. Ndiaye, O. Faye, C. T. Diagne, N. Dia, M. Naghibosadat, A. McGeer, S. Muberaka, I. P. Moukandja, S. Ndidi, C. B. Tauil, J. B. Lekana-Douki, C. Loucoubar, O. Faye, A. Sall, K. G. Magalhaes, N. Weis, R. Kozak, G. P. Kobinger, and H. Fausther-Bovendo. 2022. 'Cross-reactive immunity against SARS-CoV-2 N protein in Central and West Africa precedes the COVID-19 pandemic', Sci Rep, 12: 12962. https://doi.org/10.1038/s41598-022-17241-9
Salam Sawadogo, KoumpingninNebie, Catherine Traore, Abdoul-Guayini Sawadogo, Donatien Kima, Malick Nabaloum, Eric Arnaud Diendéré, Henri Gautier Ouedraogo, Eléonore Kafando, and Yéri Esther Hien. (2023). 'Seroprevalence of SARS-CoV-2 antibodies among sickle cell patients in Burkina Faso', Revue tunisienne de Biolgie clinique, 30: 20-27.
Steinhardt, L. C., F. Ige, N. C. Iriemenam, S. M. Greby, Y. Hamada, M. Uwandu, M. Aniedobe, K. A. Stafford, A. Abimiku, N. Mba, N. Agala, O. Okunoye, A. Mpamugo, M. Swaminathan, E. Onokevbagbe, T. Olaleye, I. Odoh, B. J. Marston, M. Okoye, I. Abubakar, M. X. Rangaka, E. Rogier, and R. Audu. (2021). Cross-Reactivity of Two SARS-CoV-2 Serological Assays in a Setting Where Malaria Is Endemic, J Clin Microbiol, 59: e00514-21. https://doi.org/10.1128/JCM.00514-21
Struck, N. S., E. Lorenz, C. Deschermeier, D. Eibach, J. Kettenbeil, W. Loag, S. A. Brieger, A. M. Ginsbach, C. Obirikorang, O. Maiga-Ascofare, Y. A. Sarkodie, E. E. A. Boham, E. A. Adu, G. Asare, A. Amoako-Adusei, A. Yawson, A. O. Boakye, J. Deke, N. S. Almoustapha, L. Adu-Amoah, I. K. Duah, T. A. Ouedraogo, V. Boudo, B. Rushton, C. Ehmen, D. Fusco, L. Gunga, D. Benke, Y. Hoppner, Z. T. Rasolojaona, T. Rasamoelina, R. A. Rakotoarivelo, R. Rakotozandrindrainy, B. Coulibaly, A. Sie, A. A. Awuah, J. H. Amuasi, A. Souares, and J. May. (2022). 'High seroprevalence of SARS-CoV-2 in Burkina-Faso, Ghana and Madagascar in 2021: a population-based study', BMC Public Health, 22: 1676. https://doi.org/10.1186/s12889-022-13918-y
Talla, C., C. Loucoubar, J. L. Roka, M. A. Barry, S. Ndiaye, M. Diarra, M. S. Thiam, O. Faye, M. Dia, M. Diop, O. Ndiaye, A. Tall, R. Faye, A. A. Mbow, B. Diouf, J. P. Diallo, I. M. Keita, M. Ndiaye, T. Woudenberg, M. White, J. Ting, C. T. Diagne, O. Pasi, B. Diop, A. A. Sall, I. Vigan-Womas, and O. Faye. (2022). 'Seroprevalence of anti-SARS-CoV-2 antibodies in Senegal: a national population-based cross-sectional survey, between October and November 2020', IJID Reg, 3: 117-25.
Traore, A., M. A. Guindo, D. Konate, B. Traore, S. A. Diakite, S. Kante, A. Dembele, A. Cisse, N. C. Incandela, M. Kodio, Y. I. Coulibaly, O. Faye, A. V. Kajava, F. Pratesi, P. Migliorini, A. M. Papini, L. Pacini, P. Rovero, F. Errante, M. Diakite, M. Arevalo-Herrera, S. Herrera, G. Corradin, and S. Balam. (2022). Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas, Front Immunol, 13: 856033. https://doi.org/10.3389/fimmu.2022.856033
Tso, F. Y., S. J. Lidenge, P. B. Pena, A. A. Clegg, J. R. Ngowi, J. Mwaiselage, O. Ngalamika, P. Julius, J. T. West, and C. Wood. (2021). 'High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa', Int J Infect Dis, 102: 577-83.
https://doi.org/10.1016/j.ijid.2020.10.104
Woodford, J., I. Sagara, A. Dicko, A. Zeguime, M. Doucoure, J. Kwan, I. Zaidi, J. Doritchamou, M. Snow-Smith, N. Alani, J. Renn, I. Kosik, J. Holly, J. Yewdell, D. Esposito, K. Sadtler, and P. Duffy. (2021). 'Severe Acute Respiratory Syndrome Coronavirus 2 Seroassay Performance and Optimization in a Population With High Background Reactivity in Mali', J Infect Dis, 224: 2001-09. https://doi.org/10.1093/infdis/jiab498
Zio, S., B. Lamien, S. Tiemounou, Y. Adaman, I. Tougri, M. Beidari, and Owys Boris. (2022). Multi-outputs Gaussian process for predicting Burkina Faso COVID-19 spread using correlations from the weather parameters, Infect Dis Model, 7: 448-62. https://doi.org/10.1016/j.idm.2022.06.006
Citations |
 |
 |
 |
 |
